{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:45:42Z","timestamp":1760147142088,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>From the very first months of the pandemic, it became apparent that a variety of skin reactions could occur during COVID-19 disease, starting with \u2018erythema-pernio\u2019-type lesions, similar to chilblains [...]<\/jats:p>","DOI":"10.3390\/vaccines11010152","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T02:06:03Z","timestamp":1673402763000},"page":"152","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cutaneous Manifestations of SARS-CoV-2, Cutaneous Adverse Reactions to Vaccines Anti-SARS-CoV-2 and Clinical\/Dermoscopical Findings: Where We Are and Where We Will Go"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0325-4316","authenticated-orcid":false,"given":"Gerardo","family":"Cazzato","sequence":"first","affiliation":[{"name":"Section of Molecular Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari Aldo Moro, 70124 Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D3271052017","article-title":"Cutaneous manifestations of COVID-19","volume":"27","author":"Wang","year":"2021","journal-title":"Dermatol. Online J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3390\/pediatric13020025","article-title":"Inflammatory Skin Lesions in Three SARS-CoV-2 Swab-Negative Adolescents: A Possible COVID-19 Sneaky Manifestation?","volume":"13","author":"Ingravallo","year":"2021","journal-title":"Pediatr. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_4","first-page":"e300","article-title":"Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection","volume":"34","author":"Berlingin","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaad.2020.04.161","article-title":"Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France","volume":"83","author":"Bouaziz","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e13896","DOI":"10.1111\/dth.13896","article-title":"Cutaneous manifestations in hospitalized patients diagnosed as COVID-19","volume":"33","author":"Askin","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_7","first-page":"e574","article-title":"The broad spectrum of dermatological manifestations in COVID-19: Clinical and histopathological features learned from a series of 34 cases","volume":"34","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jaad.2020.05.073","article-title":"Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy","volume":"83","author":"Recalcati","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1111\/jdv.16693","article-title":"COVID-19: How it can look on the skin. Clinical and pathological features in 20 COVID-19 patients observed in Bologna, north-eastern Italy","volume":"34","author":"Gaspari","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/wound.2020.1309","article-title":"Cutaneous Manifestations of COVID-19: A Systematic Review","volume":"10","author":"Singh","year":"2021","journal-title":"Adv. Wound Care"},{"doi-asserted-by":"crossref","unstructured":"Cazzato, G., Mazzia, G., Cimmino, A., Colagrande, A., Sablone, S., Lettini, T., Rossi, R., Santarella, N., Elia, R., and Nacchiero, E. (2021). SARS-CoV-2 and Skin: The Pathologist\u2019s Point of View. Biomolecules, 11.","key":"ref_11","DOI":"10.3390\/biom11060838"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.19327","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: Histopathological, immunohistochemical and ultrastructural study of seven paediatric cases","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/cup.13866","article-title":"Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein","volume":"48","author":"Ko","year":"2021","journal-title":"J. Cutan. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.mayocp.2021.01.009","article-title":"Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms","volume":"96","author":"Cappel","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_15","first-page":"e13476","article-title":"Cutaneous side-effects of the potential COVID-19 drugs","volume":"33","author":"Lotti","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1111\/jdv.16544","article-title":"Vascular skin symptoms in COVID-19: A French observational study","volume":"34","author":"Bouaziz","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.det.2021.05.016","article-title":"COVID-19 Vaccines and the Skin: The Landscape of Cutaneous Vaccine Reactions Worldwide","volume":"39","author":"Sun","year":"2021","journal-title":"Dermatol. Clin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jdv.17744","article-title":"Cutaneous findings following COVID-19 vaccination: Review of world literature and own experience","volume":"36","author":"Gambichler","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"doi-asserted-by":"crossref","unstructured":"Ambrogio, F., Laface, C., Sbarra, G., Filotico, R., Ranieri, G., Barlusconi, C., De Marco, A., Cazzato, G., Bonamonte, D., and Romita, P. (2022). A Case of Purpura Annularis Telangiectodes of Majocchi after Anti-SARS-CoV-2 Pfizer-BioNTech Vaccine: Is There an Association?. Vaccines, 10.","key":"ref_20","DOI":"10.3390\/vaccines10111972"},{"doi-asserted-by":"crossref","unstructured":"Cazzato, G., Romita, P., Foti, C., Lobreglio, D., Trilli, I., Colagrande, A., Ingravallo, G., and Resta, L. (2022). Development of Flat Warts on the Cheeks after BioNTech-Pfizer BNT162b2 Vaccine: Is There a Correlation?. Vaccines, 10.","key":"ref_21","DOI":"10.3390\/vaccines10040532"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/ACI.0000000000000655","article-title":"Immediate hypersensitivity reactions to steroids and steroid containing medications","volume":"20","author":"Rutkowski","year":"2020","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2022","journal-title":"Immunity"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.clindermatol.2021.07.011","article-title":"The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin","volume":"39","author":"Magro","year":"2021","journal-title":"Clin. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"doi-asserted-by":"crossref","unstructured":"Restivo, V., Candore, G., Barrale, M., Caravello, E., Graziano, G., Onida, R., Raineri, M., Tiralongo, S., and Brusca, I. (2021). Allergy to Polyethilenglicole of Anti-SARS CoV2 Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of Future Exposure to SARS-CoV2. Vaccines, 9.","key":"ref_26","DOI":"10.3390\/vaccines9050412"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/1\/152\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:06:13Z","timestamp":1760119573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/1\/152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["vaccines11010152"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11010152","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2023,1,10]]}}}